BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 21163921)

  • 1. Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis.
    Smith NL; Rice KM; Bovill EG; Cushman M; Bis JC; McKnight B; Lumley T; Glazer NL; van Hylckama Vlieg A; Tang W; Dehghan A; Strachan DP; O'Donnell CJ; Rotter JI; Heckbert SR; Psaty BM; Rosendaal FR
    Blood; 2011 Jun; 117(22):6007-11. PubMed ID: 21163921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLEC4M and STXBP5 gene variations contribute to von Willebrand factor level variation in von Willebrand disease.
    Sanders YV; van der Bom JG; Isaacs A; Cnossen MH; de Maat MP; Laros-van Gorkom BA; Fijnvandraat K; Meijer K; van Duijn CM; Mauser-Bunschoten EP; Eikenboom J; Leebeek FW;
    J Thromb Haemost; 2015 Jun; 13(6):956-66. PubMed ID: 25832887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels.
    Antoni G; Oudot-Mellakh T; Dimitromanolakis A; Germain M; Cohen W; Wells P; Lathrop M; Gagnon F; Morange PE; Tregouet DA
    BMC Med Genet; 2011 Aug; 12():102. PubMed ID: 21810271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of genetic variations in syntaxin-binding protein-5 and syntaxin-2 on von Willebrand factor concentration and cardiovascular risk.
    van Loon JE; Leebeek FW; Deckers JW; Dippel DW; Poldermans D; Strachan DP; Tang W; O'Donnell CJ; Smith NL; de Maat MP
    Circ Cardiovasc Genet; 2010 Dec; 3(6):507-12. PubMed ID: 21156930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of genetic variation in STXBP5 and STX2 on von Willebrand factor and bleeding phenotype in type 1 von Willebrand disease patients.
    van Loon JE; Sanders YV; de Wee EM; Kruip MJ; de Maat MP; Leebeek FW
    PLoS One; 2012; 7(7):e40624. PubMed ID: 22792389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Thrombotic Function of a Human SNP in STXBP5 Revealed by CRISPR/Cas9 Gene Editing in Mice.
    Zhu QM; Ko KA; Ture S; Mastrangelo MA; Chen MH; Johnson AD; O'Donnell CJ; Morrell CN; Miano JM; Lowenstein CJ
    Arterioscler Thromb Vasc Biol; 2017 Feb; 37(2):264-270. PubMed ID: 28062498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide association studies identify genetic loci for low von Willebrand factor levels.
    van Loon J; Dehghan A; Weihong T; Trompet S; McArdle WL; Asselbergs FW; Chen MH; Lopez LM; Huffman JE; Leebeek FW; Basu S; Stott DJ; Rumley A; Gansevoort RT; Davies G; Wilson JJ; Witteman JC; Cao X; de Craen AJ; Bakker SJ; Psaty BM; Starr JM; Hofman A; Wouter Jukema J; Deary IJ; Hayward C; van der Harst P; Lowe GD; Folsom AR; Strachan DP; Smith N; de Maat MP; O'Donnell C
    Eur J Hum Genet; 2016 Jul; 24(7):1035-40. PubMed ID: 26486471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Variation in the Syntaxin-Binding Protein STXBP5 in Type 1 von Willebrand Disease Patients.
    Lind-Halldén C; Manderstedt E; Carlberg D; Lethagen S; Halldén C
    Thromb Haemost; 2018 Aug; 118(8):1382-1389. PubMed ID: 29972863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of genetic variations with nonfatal venous thrombosis in postmenopausal women.
    Smith NL; Hindorff LA; Heckbert SR; Lemaitre RN; Marciante KD; Rice K; Lumley T; Bis JC; Wiggins KL; Rosendaal FR; Psaty BM
    JAMA; 2007 Feb; 297(5):489-98. PubMed ID: 17284699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common and Rare Variants in Genes Associated with von Willebrand Factor Level Variation: No Accumulation of Rare Variants in Swedish von Willebrand Disease Patients.
    Manderstedt E; Lind-Halldén C; Lethagen S; Halldén C
    TH Open; 2020 Oct; 4(4):e322-e331. PubMed ID: 33145474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of ADAMTS13, VWF and F8 genes in deep vein thrombosis.
    Pagliari MT; Cairo A; Boscarino M; Mancini I; Pappalardo E; Bucciarelli P; Martinelli I; Rosendaal FR; Peyvandi F
    PLoS One; 2021; 16(10):e0258675. PubMed ID: 34662354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variants in Cell Adhesion Molecule 1 (CADM1): a validation study of a novel endothelial cell venous thrombosis risk factor.
    de Haan HG; Bezemer ID; Vossen CY; van Hylckama Vlieg A; Böehringer S; Hasstedt SJ; Levy S; Rosendaal FR; Bovill EG
    Thromb Res; 2014 Dec; 134(6):1186-92. PubMed ID: 25306186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion.
    Zhu Q; Yamakuchi M; Ture S; de la Luz Garcia-Hernandez M; Ko KA; Modjeski KL; LoMonaco MB; Johnson AD; O'Donnell CJ; Takai Y; Morrell CN; Lowenstein CJ
    J Clin Invest; 2014 Oct; 124(10):4503-16. PubMed ID: 25244095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of venous thrombosis: insights from a new genome wide association study.
    Germain M; Saut N; Greliche N; Dina C; Lambert JC; Perret C; Cohen W; Oudot-Mellakh T; Antoni G; Alessi MC; Zelenika D; Cambien F; Tiret L; Bertrand M; Dupuy AM; Letenneur L; Lathrop M; Emmerich J; Amouyel P; Trégouët DA; Morange PE
    PLoS One; 2011; 6(9):e25581. PubMed ID: 21980494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: The CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium.
    Smith NL; Chen MH; Dehghan A; Strachan DP; Basu S; Soranzo N; Hayward C; Rudan I; Sabater-Lleal M; Bis JC; de Maat MP; Rumley A; Kong X; Yang Q; Williams FM; Vitart V; Campbell H; Mälarstig A; Wiggins KL; Van Duijn CM; McArdle WL; Pankow JS; Johnson AD; Silveira A; McKnight B; Uitterlinden AG; ; Aleksic N; Meigs JB; Peters A; Koenig W; Cushman M; Kathiresan S; Rotter JI; Bovill EG; Hofman A; Boerwinkle E; Tofler GH; Peden JF; Psaty BM; Leebeek F; Folsom AR; Larson MG; Spector TD; Wright AF; Wilson JF; Hamsten A; Lumley T; Witteman JC; Tang W; O'Donnell CJ
    Circulation; 2010 Mar; 121(12):1382-92. PubMed ID: 20231535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation.
    Goumidi L; Thibord F; Wiggins KL; Li-Gao R; Brown MR; van Hylckama Vlieg A; Souto JC; Soria JM; Ibrahim-Kosta M; Saut N; Daian D; Olaso R; Amouyel P; Debette S; Boland A; Bailly P; Morrison AC; Mook-Kanamori DO; Deleuze JF; Johnson A; de Vries PS; Sabater-Lleal M; Chiaroni J; Smith NL; Rosendaal FR; Chasman DI; Trégouët DA; Morange PE
    Blood; 2021 Apr; 137(17):2394-2402. PubMed ID: 33512453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in the von Willebrand factor gene is associated with von Willebrand factor levels and with the risk for cardiovascular disease.
    van Schie MC; de Maat MP; Isaacs A; van Duijn CM; Deckers JW; Dippel DW; Leebeek FW
    Blood; 2011 Jan; 117(4):1393-9. PubMed ID: 20940418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction networks of Weibel-Palade body regulators syntaxin-3 and syntaxin binding protein 5 in endothelial cells.
    Schillemans M; Karampini E; Hoogendijk AJ; Wahedi M; van Alphen FPJ; van den Biggelaar M; Voorberg J; Bierings R
    J Proteomics; 2019 Aug; 205():103417. PubMed ID: 31201948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide association study for circulating tissue plasminogen activator levels and functional follow-up implicates endothelial STXBP5 and STX2.
    Huang J; Huffman JE; Yamakuchi M; Trompet S; Asselbergs FW; Sabater-Lleal M; Trégouët DA; Chen WM; Smith NL; Kleber ME; Shin SY; Becker DM; Tang W; Dehghan A; Johnson AD; Truong V; Folkersen L; Yang Q; Oudot-Mellkah T; Buckley BM; Moore JH; Williams FM; Campbell H; Silbernagel G; Vitart V; Rudan I; Tofler GH; Navis GJ; Destefano A; Wright AF; Chen MH; de Craen AJ; Worrall BB; Rudnicka AR; Rumley A; Bookman EB; Psaty BM; Chen F; Keene KL; Franco OH; Böhm BO; Uitterlinden AG; Carter AM; Jukema JW; Sattar N; Bis JC; Ikram MA; ; Sale MM; McKnight B; Fornage M; Ford I; Taylor K; Slagboom PE; McArdle WL; Hsu FC; Franco-Cereceda A; Goodall AH; Yanek LR; Furie KL; Cushman M; Hofman A; Witteman JC; Folsom AR; Basu S; Matijevic N; van Gilst WH; Wilson JF; Westendorp RG; Kathiresan S; Reilly MP; ; Tracy RP; Polasek O; Winkelmann BR; Grant PJ; Hillege HL; Cambien F; Stott DJ; Lowe GD; Spector TD; Meigs JB; Marz W; Eriksson P; Becker LC; Morange PE; Soranzo N; Williams SM; Hayward C; van der Harst P; Hamsten A; Lowenstein CJ; Strachan DP; O'Donnell CJ;
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1093-101. PubMed ID: 24578379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multi-stage multi-design strategy provides strong evidence that the BAI3 locus is associated with early-onset venous thromboembolism.
    Antoni G; Morange PE; Luo Y; Saut N; Burgos G; Heath S; Germain M; Biron-Andreani C; Schved JF; Pernod G; Galan P; Zelenika D; Alessi MC; Drouet L; Visvikis-Siest S; Wells PS; Lathrop M; Emmerich J; Tregouet DA; Gagnon F
    J Thromb Haemost; 2010 Dec; 8(12):2671-9. PubMed ID: 20946148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.